Xinya Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xinya Peng has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Baolin Qian
Department of Hepatobiliary Surgery Affiliated Hospital of Southwest Medical University Luzhou China
1 shared publicationDanna Xie
Department of Oncology The Affiliated Hospital of Southwest Medical University Luzhou China
1 shared publication- Fei Xue
Key Laboratory of Entomology and Pest Control Engineering, College of Plant Protection, Southwest University, Chongqing, China
1 shared publication Guangmao Shen
Key Laboratory of Entomology and Pest Control Engineering, College of Plant Protection, Southwest University, Chongqing, China
1 shared publication- Jing Yang
School of Pharmacy, Southwest Medical University, Luzhou 646000, China
1 shared publication - Kun Qian
College of Plant Protection, Southwest University, Chongqing 400715, China
1 shared publication
Latest Publications
- Open Access
- 29 October 2020
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10, 598048
Can Elderly Patients With Pancreatic Cancer Gain Survival Advantages Through More Radical Surgeries? A SEER-Based Analysis
Background and Aims: In recent years, the best treatment method for pancreatic cancer in elderly patients has remained controversial. Surgery is the main treatment modality for pancreatic cancer. This study aimed to determine whether elderly patients with pancreatic cancer can gain survival advantages through more active and radical surgical treatment and evaluate the best treatment method and potential prognostic factors. Methods: From the Surveillance, Epidemiology, and End Results program (SEER) database, 10,557 elderly patients (aged ≥65 years) with pancreatic cancer were included as Cohort 1, and Propensity Score Matching (PSM) evaluation was performed to generate Cohort 2 (424 pairs). Overall Survival (OS) and Cause-Specific Survival (CSS) were determined using Kaplan–Meier survival curves, and differences were assessed using the Log-rank test. Multivariate logistic regression analysis and the forest plot of hazard ratio (HR) was made to assess the association between potential prognostic factors, including surgery and different surgical methods, and survival in elderly patients. Results: We identified 10,557 eligible patients with pancreatic cancer, who formed Cohort 1. The total OS and CSS in the surgery group were significantly higher than those in the non-surgery group (P < 0.001). Age, stage (AJCC 8th), grade, lymph node metastasis, radiation, chemotherapy, and surgical methods were independent factors affecting the prognosis of elderly patients. In Cohort 2, Total pancreatectomy (Total PT) had the lowest risk ratio (HR = 0.31, P < 0.001) and longest median CSS (18.000 months), while Extension Total pancreatectomy (Ex-Total PT, HR = 0.34, P < 0.001) showed the lower median CSS (17.000 months) and median OS (14.000 months). Partial pancreatectomy (Partial PT, HR = 0.46, P < 0.001) showed the lowest median CSS (13.000 months) and median OS (12.000 months), although they were still higher than the median CSS (6.000 months) and median OS (5.000 months) in the non-surgery group. Conclusions: Based on the SEER database, surgical treatment is an independent prognostic factor in elderly patients with pancreatic cancer. Compared with other surgical methods, Total PT can offer elderly patients the best survival advantages. However, Ex-Total PT, a more radical method, does not seem to be the best treatment option for the survival and benefit of elderly patients.
- 29 October 2020
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10, 598048
Open AccessCan Elderly Patients With Pancreatic Cancer Gain Survival Advantages Through More Radical Surgeries? A SEER-Based Analysis
Background and Aims: In recent years, the best treatment method for pancreatic cancer in elderly patients has remained controversial. Surgery is the main treatment modality for pancreatic cancer. This study aimed to determine whether elderly patients with pancreatic cancer can gain survival advantages through more active and radical surgical treatment and evaluate the best treatment method and potential prognostic factors. Methods: From the Surveillance, Epidemiology, and End Results program (SEER) database, 10,557 elderly patients (aged ≥65 years) with pancreatic cancer were included as Cohort 1, and Propensity Score Matching (PSM) evaluation was performed to generate Cohort 2 (424 pairs). Overall Survival (OS) and Cause-Specific Survival (CSS) were determined using Kaplan–Meier survival curves, and differences were assessed using the Log-rank test. Multivariate logistic regression analysis and the forest plot of hazard ratio (HR) was made to assess the association between potential prognostic factors, including surgery and different surgical methods, and survival in elderly patients. Results: We identified 10,557 eligible patients with pancreatic cancer, who formed Cohort 1. The total OS and CSS in the surgery group were significantly higher than those in the non-surgery group (P < 0.001). Age, stage (AJCC 8th), grade, lymph node metastasis, radiation, chemotherapy, and surgical methods were independent factors affecting the prognosis of elderly patients. In Cohort 2, Total pancreatectomy (Total PT) had the lowest risk ratio (HR = 0.31, P < 0.001) and longest median CSS (18.000 months), while Extension Total pancreatectomy (Ex-Total PT, HR = 0.34, P < 0.001) showed the lower median CSS (17.000 months) and median OS (14.000 months). Partial pancreatectomy (Partial PT, HR = 0.46, P < 0.001) showed the lowest median CSS (13.000 months) and median OS (12.000 months), although they were still higher than the median CSS (6.000 months) and median OS (5.000 months) in the non-surgery group. Conclusions: Based on the SEER database, surgical treatment is an independent prognostic factor in elderly patients with pancreatic cancer. Compared with other surgical methods, Total PT can offer elderly patients the best survival advantages. However, Ex-Total PT, a more radical method, does not seem to be the best treatment option for the survival and benefit of elderly patients.
- 29 October 2018
- Published by Wiley in Pest Management Science
- Vol. 75 (5) , 1354-1360
Preparation of cyflumetofen nanocapsules and study on the controlled release performance and its field efficacy
BACKGROUND: In this study, 5% cyflumetofen nanocapsules were prepared by interfacial polymerization with isophorone diisocyanate and polyethylene glycol as the reaction monomer, and tristyrylphenol polyoxyethylene ether (601‐P) as the emulsifier. The physical, chemical and sustained release properties of cyflumetofen nanocapsules were characterized using scanning electron microscopy, field emission scanning electron microscopy, laser particle size analysis, Fourier transform infrared spectroscopy, contact angles testing and high‐performance liquid chromatography.RESULTS: The results indicated that cyflumetofen nanocapsules were spherical, with an average particle size of 100 nm, and an encapsulation efficiency and loading rate of 86% and 32%, respectively. The thermal and cold storage stabilities of cyflumetofen nanocapsules were good. Under high temperature, lower pH or a high core–wall ratio, nanoparticle release is faster. The field efficacy experiment indicated that the efficacy of cyflumetofen nanocapsules against Panonychus citri reached 97%, 30 days after spraying, significantly greater than that of a 20% cyflumetofen suspension.CONCLUSION: It is important to increase the stability, lengthen the release period and improve the efficacy of cyflumetofen in cyflumetofen nanocapsules. © 2018 Society of Chemical Industry
- 29 October 2018
- Published by Wiley in Pest Management Science
- Vol. 75 (5) , 1354-1360
Preparation of cyflumetofen nanocapsules and study on the controlled release performance and its field efficacy
BACKGROUND: In this study, 5% cyflumetofen nanocapsules were prepared by interfacial polymerization with isophorone diisocyanate and polyethylene glycol as the reaction monomer, and tristyrylphenol polyoxyethylene ether (601‐P) as the emulsifier. The physical, chemical and sustained release properties of cyflumetofen nanocapsules were characterized using scanning electron microscopy, field emission scanning electron microscopy, laser particle size analysis, Fourier transform infrared spectroscopy, contact angles testing and high‐performance liquid chromatography.RESULTS: The results indicated that cyflumetofen nanocapsules were spherical, with an average particle size of 100 nm, and an encapsulation efficiency and loading rate of 86% and 32%, respectively. The thermal and cold storage stabilities of cyflumetofen nanocapsules were good. Under high temperature, lower pH or a high core–wall ratio, nanoparticle release is faster. The field efficacy experiment indicated that the efficacy of cyflumetofen nanocapsules against Panonychus citri reached 97%, 30 days after spraying, significantly greater than that of a 20% cyflumetofen suspension.CONCLUSION: It is important to increase the stability, lengthen the release period and improve the efficacy of cyflumetofen in cyflumetofen nanocapsules. © 2018 Society of Chemical Industry